课题基金 / 基金详情

Studies of differentiation mechanisms of hematopoietic stem cells using cytokine-receptor transgenic mice

Studies of differentiation mechanisms of hematopoietic stem cells using cytokine-receptor transgenic mice
利用细胞因子受体转基因小鼠研究造血干细胞分化机制
批准号:
10307020
负责人:
NAKAHATA Tatsutoshi
金额:
$24.83万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999

项目摘要

项目成果

NAKAHATA Tatsutoshi的其他基金

相似基金

相关文献

中文摘要
翻译
粒细胞-巨噬细胞集落刺激因子(GM-CSF)通过靶细胞表面表达的细胞表面受体刺激髓系祖细胞的增殖和成熟。为了分析hGMR受体表达与造血细胞分化的关系,利用hGMR α和hGMR β cDNA构建了在造血细胞发育的各个阶段表达hGMR的转基因小鼠(Tg小鼠)。hGM-CSF支持各种类型的集落形成,包括原始细胞、红系细胞(E)、巨核细胞(Meg)和混合造血集落。对Tg小鼠施用hGM-CSF不仅导致其外周血中的中性粒细胞、单核细胞、嗜酸性粒细胞、NK细胞的增加,而且还导致红细胞的增加。为了阐明GM-CSFR信号传导是否可以补偿红细胞生成中的促红细胞生成素受体(EPOR)信号传导,我们接下来产生双突变小鼠,hGM-CSFR+/+和EPOR-/-。虽然双突变小鼠是胚胎致死的,hGM-CSF诱导大量的红系集落从双突变小鼠胎肝细胞的第14天。我们还产生了具有野生型人G-CSFR、野生型鼠G-CSFR的普遍表达的Tg小鼠。在骨髓和脾细胞甲基纤维素集落实验中,G-CSF不仅对粒细胞有促进作用,而且对巨噬细胞、巨核细胞、肥大细胞、红系细胞和更多的原始造血祖细胞在含血清和无血清培养中均有促进增殖和分化的作用。这些结果表明,当功能性GM-CSFR或G-CSFR存在于细胞表面上时,两种细胞因子均不诱导对嗜中性粒细胞和巨噬细胞谱系的排他性定型。使用Tg小鼠的体外和体内研究表明,当受体表达时,细胞因子如hGM-CSF或hG-CSF支持各种造血祖细胞的生长,但不改变它们的定型程序,因此有利于“随机模型”而不是“确定性模型”。
英文摘要
Granulocyte-macrophage colony stimulating factor (GM-CSF) stimulates proliferation and maturation of myeloid progenitor cells through cell surface receptors expressed on target cells. To analyze the relationship between receptor expression and differentiation of hemopoietic cells, transgenic mice (Tg mice) which express hGMR at all stages of hemopoitic cell development were generated using hGMR α and β cDNAs. hGM-CSF supported colony formation of various types including blast cell, erythroid (E), megakaryocyte (Meg), and mixed hematopoietic colonies. Administration of hGM-CSF to Tg mice resulted in increase of not only neutrophils, monocyte, eosinophils, NK cells but also erythrocytes in their peripheral blood. To clalify whether GM-CSFR signaling can compensate erythropoietin receptor (EPOR) signaling in erythropoiesis, we next generated double mutant mice, hGM-CSFR+/+ and EPOR-/-. Although double mutant mice were embryonic lethal, hGM-CSF induced a large number of erythroid colonies from day 14 fetal liver cells of double mutant mice. We also generated Tg mice that had ubiquitous expressions of wild type human G-CSFR, wild type murine G-CSFR. In methylcellulose colony assay of bone marrow and spleen cells G-CSF have an effect on promoting the proliferation and differentiation of not only granulocyte but also macrophage, megakaryocyte, mast cells, erythroid and more primitive hematopoietic progenitors in both serum-containing and -free culture. These results shows that when functional GM-CSFR or G-CSFR are present on the cell surface, both cytokines does not induce exclusive commitment to the neutrophil and macrophage lineages. In vitro and in vivo studies using the Tg mice indicated that cytokines such as hGM-CSF or hG-CSF supported the growth of various hematopoietic progenitors when the receptor was expressed, but did not alter their commitment program, thus favoring the "stochastic model" rather than the "deterministic model".
期刊论文(91)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Toru H.,Pawankar R.,Yata J.,Nakahata T.,et al: "Human mast cells produce interleukin-13 by high affinity IgE receptor cross-linking : enhanced IL-13 production by IL-4 primed human mast cells." J.Allergy and Clin.Immunol.(in press). (1998)
Toru H.、Pawankar R.、Yata J.、Nakahata T. 等人:“人类肥大细胞通过高亲和力 IgE 受体交联产生白细胞介素 13:通过 IL-4 引发的人类肥大细胞增强 IL-13 的产生。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kobayashi M.,Ueda K.,Nishihira H.,Nakahata T.,et al: "Serum granulocyte colony-stimulating factor levels in patients with chronic neutropenia of childhood : Modulation of G-CSF levels by myeloid precursor cell mass." Brit.J.Haematol.(in press). (1998)
Kobayashi M.、Ueda K.、Nishihira H.、Nakahata T.等人:“儿童慢性中性粒细胞减少症患者的血清粒细胞集落刺激因子水平:骨髓前体细胞团对 G-CSF 水平的调节。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Nishihara M., Wada Y., Nakahata T., Maekawa T., et al: "A combination of stem cell factor and granulocyte colony-stimulating factor enhances the growth of human progenitor B cells supported by murine stromal cell line MS-5." Eur.J.Immunol.28. 855-864 (199
Nishihara M.、Wada Y.、Nakahata T.、Maekawa T. 等人:“干细胞因子和粒细胞集落刺激因子的组合可增强小鼠基质细胞系 MS-5 支持的人类 B 祖细胞的生长。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 85 条
    Hematopoietic stem cell potential is propagated by human pluripotent stem cell-derived endothelial stroma
    • 批准号:
      24659496
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.5万
    • 财政年份:
      2012
    • 负责人:
      NAKAHATA Tatsutoshi
    • 依托单位:
    Recapitulation of phenotypes and discovery of a novel treatment with disease-specific human ES/ iPS cells from various hereditary diseases
    • 批准号:
      22249042
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $30.87万
    • 财政年份:
      2010
    • 负责人:
      NAKAHATA Tatsutoshi
    • 依托单位:
    Analysis of proliferation and differentiation of human embryonic stem cells and research for clinical application
    • 批准号:
      19109006
    • 项目类别:
      Grant-in-Aid for Scientific Research (S)
    • 资助金额:
      $69.89万
    • 财政年份:
      2007
    • 负责人:
      NAKAHATA Tatsutoshi
    • 依托单位:
    molecular cloning of self-renewal factor for hematopoietic stem cells and its clinical application
    • 批准号:
      11357008
    • 项目类别:
      Grant-in-Aid for Scientific Research (A).
    • 资助金额:
      $22.4万
    • 财政年份:
      1999
    • 负责人:
      NAKAHATA Tatsutoshi
    • 依托单位:
    国内基金
    海外基金
    Foxc2介导Syap1/Akt信号通路调控破骨/成骨细胞分化促进颞下颌关节骨关节炎的机制研究
    • 批准号:
      82370979
    • 项目类别:
      面上项目
    • 资助金额:
      48.00万元
    • 批准年份:
      2023
    • 负责人:
      张善勇
    • 依托单位:
    BRD4通过结合TEAD1调控β细胞增殖分化的机制研究
    • 批准号:
      82370801
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      李峰
    • 依托单位:
    22q11.2染色体微重复影响TOP3B表达并导致腭裂发生的机制研究
    • 批准号:
      82370906
    • 项目类别:
      面上项目
    • 资助金额:
      48.00万元
    • 批准年份:
      2023
    • 负责人:
      代杰文
    • 依托单位:
    新生儿坏死性小肠结肠炎中去泛素化酶USP15调控ILC3分化损伤肠道粘膜屏障的致病机制研究
    • 批准号:
      82371711
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      吕志宝
    • 依托单位: